Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
50day moving average crosses 200day moving average today. Both up trending so looking very positive, especially with the very positive agm statement regarding progress and meeting market expectations.
Good signs indeed.
I see the new RNS details how Hilary Spence bought 220,000 shares.
Still showing as a sell on here?
Anyway good to see directors getting behind the share.
Hoping this get's back to above 8p in the near future..........
And now sentiment on top of fundamentals and technicals.
A golden cross would encouraging.
Fundamentals looking very good now and so are technicals. 200day moving average has turned with a clear uptrend forming. 50day moving average should cross over the 200day in the next 5days forming a golden cross.
Now on . atb
Sheeesh well maybe its early and no one has read the news but 4% a bit slow and two of the buys this morning were from me for two pensions!
Clearly, the market either not aware of COS or not that impressed. Meh! Holding for better times.
Well overdue here. Company finally talking to the market.
Agree.
"Sharecast News) - Developer and manufacturer of biomaterials and regenerative medicines Collagen Solutions has signed distribution agreements with two new Chinese channel partners - Dakewe Biotech Company and Shanghai Regenic Biomedical - it announced on Tuesday.
The AIM-traded company said the appointment of the channel partners followed the restructuring of its presence in China, and the securing of export licences, earlier this year.
Its said the move was in line with its stated strategy to gain more flexibility in engaging with and providing technical support to customers in China, enabling it to take advantage of opportunities within the significant territory.
Dakewe Biotech Company was founded in 1999, with headquarters in Shenzhen and subsidiary offices in Beijing, Shanghai, Hong Kong, Guangzhou, Wuhan and Chengdu."
Should be a good day for the share price!
"We are on track to meet our key initiatives for the year, including achieving financial performance to bring us in line with market expectations. Our commercial execution plans are on track, including the recently announced signing of new distribution partners in China and new development agreements closed in the first quarter of this year that offset a previously announced specific risk with a Korean customer. ChondroMimetic® is on track for both CE Mark and first-in-man surgery in this financial year, following a successful audit by our notified body regulator this month. "We are currently in negotiations with multiple distributors in Europe, which we expect to conclude in parallel with the ChondroMimetic® CE Mark. We also recently completed the initial animal studies for our proprietary bone graft product that will support partner discussions at the upcoming North American Spine Society meeting in September. Operationally, our New Zealand restructuring initiative is delivering the expected synergies and benefits, as the assets related to collagen production and R&D have been relocated to the UK and USA respectively with operational setup and validation underway according to plan. The New Zealand team is now fully focused on the tissue business and has already identified several new customer opportunities. Finally, we will continue to deliver more visibility and metrics to our investors relating to the value and progress within our core business."
http://ir.collagensolutions.com/content/news/2018/210818.asp
Hopefully we will get some updates released in an AGM statement like last year.
Nice research paper on ChondroMimetic http://ir.collagensolutions.com/pdf/research/Hardman_Research_26Feb2018.pdf
This company looks to have a lot of support with 43% of stock in major shareholders hands and 17% with directors. Leaves only 40% for pi’s and thats assuming there aren’t other ii’s with smaller stakes.
Yep encouraging progress over the past week. COS seems to be in favour again with small investors.
Still on the up..no mad spikes perfect.
Starting to gather some serious momentum.
Looks like waking...finally .
Maybe, maybe not. Would like to see this climbing through 5p on a steady flow of good news.
20% out of nowhere a bit strange imo.
AIM is risky and very volatile. I know some of the guys in this company - on my watch list. Great potential but a few issues to deal with first.